https://qfrsolutions.com/the-pharmaceutical-sales-rep-lives-to-fight-another-day-2/ 2014-07-14T20:35:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/10/drugpricebig-1.jpg https://qfrsolutions.com/novartis-and-google-team-up-to-develop-smart-contact-lenses/ 2014-07-15T23:16:00+00:00 https://qfrsolutions.com/wp-content/uploads/2014/07/smartlens-1.jpg https://qfrsolutions.com/leo-pharma-strikes-global-dermatology-deal-with-klok-tech/ 2014-07-17T18:34:00+00:00 https://qfrsolutions.com/wp-content/uploads/2014/07/LeoPharmaceuticals-1.jpg https://qfrsolutions.com/abbvie-finally-gets-shire-its-low-tax-base-and-enough-new-drugs-to-protect-its-future/ 2014-07-18T18:22:00+00:00 https://qfrsolutions.com/wp-content/uploads/2014/09/abbvie-1.jpg https://qfrsolutions.com/anacor-pharmaceuticals-and-sandoz-enter-into-an-agreement-for-the-commercialization-of-kerydin-in-the-united-states/ 2014-07-21T23:54:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/03/Anacor-1.jpg https://qfrsolutions.com/after-a-6-year-delay-medicines-co-bags-fda-approval-for-once-troubled-antibiotic/ 2014-08-07T20:59:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/08/fdaapproved-1.jpg https://qfrsolutions.com/cubist-pharmaceuticals-ripe-for-acquisition/ 2014-08-19T00:24:00+00:00 https://qfrsolutions.com/wp-content/uploads/2014/08/cubist-1.jpg https://qfrsolutions.com/big-pharma-doesn-t-win-the-margin-stakes-that-s-jazz-celgene-regeneron-and-alexion/ 2014-08-20T17:16:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/07/anacor_pills-1.jpg https://qfrsolutions.com/updated-abbvie-partners-with-google-s-calico-on-1-5b-r-d-operation-focused-on-aging/ 2014-09-04T20:22:00+00:00 https://qfrsolutions.com/wp-content/uploads/2014/09/abbvie-1.jpg https://qfrsolutions.com/court-ruling-against-fda-enables-more-combination-products-to-be-classified-as/ 2014-09-19T17:49:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/04/FDA-1.jpg https://qfrsolutions.com/why-great-managers-are-so-rare/ 2014-10-28T21:36:00+00:00 https://qfrsolutions.com/wp-content/uploads/2014/10/managers-1.jpg https://qfrsolutions.com/hiring-in-2015-5-trends-to-prepare-for/ 2015-01-09T17:21:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/01/hiring-1.jpg https://qfrsolutions.com/actavis-beats-on-top-and-bottom-lines-will-change-name-to-allergan/ 2015-02-18T21:00:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/06/Allerganlogo-1.png https://qfrsolutions.com/business-deaths-are-hampering-job-growth/ 2015-03-06T17:43:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/03/No-Growth-1.jpg https://qfrsolutions.com/st-jude-releases-promising-data-on-its-heart-failure-system/ 2015-03-16T21:26:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/03/stjude-1.jpg https://qfrsolutions.com/updated-fda-finalizes-accelerated-approval-pathway-for-critical-devices-aims-to-get-med-tech-to-market-faster/ 2015-04-13T15:53:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/04/FDA-1.jpg https://qfrsolutions.com/human-behavior-behind-most-surgical-errors/ 2015-06-10T00:05:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/06/surgery-1.jpg https://qfrsolutions.com/culture-why-it-s-the-hottest-topic-in-business-today/ 2015-06-15T22:12:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/06/culture-1.jpg https://qfrsolutions.com/allergan-to-buy-kythera-biopharmaceuticals-for-2-1-billion/ 2015-06-17T16:16:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/06/kythera-1.png https://qfrsolutions.com/these-are-the-fortune-500-s-fastest-growing-pharma-companies/ 2015-06-26T16:41:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/06/sciencepicture-1.jpg https://qfrsolutions.com/anacor-prescription-lotion-clears-skin-rash-in-late-stage-test/ 2015-07-13T17:23:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/07/anacor_pills-1.jpg https://qfrsolutions.com/allergan-pharma-s-biggest-dealmaker-is-on-the-hunt-again/ 2015-07-27T22:02:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/06/Allerganlogo-1.png https://qfrsolutions.com/fierce-pharma/ 2015-08-05T19:09:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/08/2018-1.jpg https://qfrsolutions.com/q2-big-5-insurers-report-better-than-expected-earnings/ 2015-08-06T16:19:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/08/Q2-1.jpg https://qfrsolutions.com/nine-explanations-for-why-the-fda-is-approving-almost-every-new-drug-application/ 2015-08-26T21:08:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/08/fdaapproved-1.jpg https://qfrsolutions.com/forget-biotech-follow-the-pharma-dividends/ 2015-08-31T17:20:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/08/aug31-1.jpg https://qfrsolutions.com/avita-nabs-54m-barda-contract-for-ongoing-pivotal-trial-stockpile-of-burn-injury-device/ 2015-10-01T23:26:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/10/RES-1.jpg https://qfrsolutions.com/big-pharma-teams-up-to-defeat-drug-pricing-proposal-in-california/ 2015-10-08T19:53:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/10/drugpricebig-1.jpg https://qfrsolutions.com/allergan-plots-117-job-cuts-in-the-wake-of-kythera-buyout/ 2015-10-14T23:14:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/10/kybella-1.jpg https://qfrsolutions.com/valeant-shares-nosedive-on-short-seller-s-phantom-sales-allegations/ 2015-10-22T22:20:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/12/Val-1.png https://qfrsolutions.com/warner-chilcott-agrees-to-plead-guilty-to-felony-health-care-fraud-scheme-and-pay-125-million-to-resolve-criminal-liability-and-false-claims-act-allegations-2/ 2015-10-29T18:47:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/10/DOJ-1.jpg https://qfrsolutions.com/statement-from-philidor-rx-services/ 2015-11-03T00:17:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/11/philidor-1.jpg https://qfrsolutions.com/q3-big-five-insurers-post-positive-results-but-struggle-on-exchanges/ 2015-11-11T23:13:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/11/stockmarket_small-1.jpg https://qfrsolutions.com/valeant-ackman-must-face-u-s-insider-trading-lawsuit/ 2015-11-12T15:36:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/12/Val-1.png https://qfrsolutions.com/pfizer-and-allergan-merge/ 2015-11-23T16:13:00+00:00 https://qfrsolutions.com/wp-content/uploads/2015/11/allerganpfizer-1.png https://qfrsolutions.com/samsung-biologics-to-build-its-third-and-largest-plant-in-south-korea/ 2015-12-01T17:42:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/10/SamsungBio-1.png https://qfrsolutions.com/galderma-and-zeltiq-announce-u-s-collaboration-in-aesthetics/ 2015-12-08T21:47:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/04/Galderma-1.png https://qfrsolutions.com/valeant-unveils-drug-pricing-distribution-pacts-with-walgreens/ 2015-12-15T23:10:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/08/VALVAL-1.jpg https://qfrsolutions.com/valeant-names-howard-schiller-as-interim-ceo/ 2016-01-06T15:54:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/12/Val-1.png https://qfrsolutions.com/anacor-pharmaceuticals-to-present-data-from-long-term-safety-study-of-crisaborole-topical-ointment-2-in-patients-with-mild-to-moderate-atopic-dermatitis-at-upcoming-medical-conference/ 2016-01-08T16:04:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/03/Anacor-1.jpg https://qfrsolutions.com/almirall-exercises-call-option-to-acquire-100-of-thermigen-llc-2/ 2016-01-12T15:49:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/01/almirall-1.jpg https://qfrsolutions.com/anacor-pharmaceuticals-announces-late-breaking-oral-presentation-of-crisaborole-topical-ointment-2-phase-3-pivotal-data/ 2016-03-01T00:28:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/03/Anacor-1.jpg https://qfrsolutions.com/valeant-asks-its-lenders-for-some-slack/ 2016-03-30T19:54:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/12/Val-1.png https://qfrsolutions.com/galderma-announces-u-s-collaboration-in-aesthetics-with-mentor-worldwide-llc/ 2016-04-04T17:07:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/04/Galderma-1.png https://qfrsolutions.com/exclusive-valeant-calls-in-investment-banks-to-weigh-options-sources/ 2016-04-15T22:38:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/12/Val-1.png https://qfrsolutions.com/unitedhealth-s-optum-targets-75-markets-for-health-center-expansion/ 2016-04-21T21:00:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/04/UnitedHealthGroup-1.jpg https://qfrsolutions.com/allergan-s-new-85m-buyout-adds-a-cosmetic-drug-to-a-growing-portfolio-2/ 2016-04-22T17:12:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/06/Allerganlogo-1.png https://qfrsolutions.com/merz-pharma-announces-new-investment-in-cytrellis-biosystems/ 2016-04-28T20:36:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/04/MCC-1.png https://qfrsolutions.com/pfizer-s-chantix-not-linked-to-serious-psychiatric-side-effects-study/ 2016-04-29T15:56:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/04/chantix-1.jpg https://qfrsolutions.com/u-s-antitrust-watchdogs-turn-to-insurers-after-halliburton-win/ 2016-05-06T22:27:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/05/LadyJustice-1.jpg https://qfrsolutions.com/mylan-snaps-up-dermatology-biz-from-investors-in-1b-deal/ 2016-05-13T18:45:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/05/Mylan-1.jpg https://qfrsolutions.com/pfizer-to-buy-anacor-in-5-2-billion-deal-for-access-to-eczema-gel/ 2016-05-16T16:39:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/05/pfizerheadquarters-1.jpg https://qfrsolutions.com/ex-warner-chilcott-sales-exec-goes-to-court-today-on-kickbacks-charges/ 2016-05-23T16:53:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/05/Insurer-1.jpg https://qfrsolutions.com/sec-raises-concerns-about-valeant-s-use-of-non-gaap-measures/ 2016-05-25T17:49:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/05/Valeant1-1.jpg https://qfrsolutions.com/jazz-pharma-to-buy-celator-in-1-5-billion-deal/ 2016-05-31T17:26:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/05/JazzPharma-1.jpg https://qfrsolutions.com/microsoft-to-buy-linkedin-for-26-2-billion-in-its-largest-deal/ 2016-06-14T16:25:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/06/MicrosoftImage-1.jpg https://qfrsolutions.com/essex-woodlands-backs-san-diego-dermal-filler-startup-with-25m/ 2016-06-15T18:38:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/06/Suneva-Logo-1.png https://qfrsolutions.com/sun-pharma-bets-on-new-products-to-boost-u-s-skincare-products-growth/ 2016-06-23T20:23:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/03/SunPharmaLogo-1.jpg https://qfrsolutions.com/pfizer-completes-acquisition-of-anacor/ 2016-06-24T19:41:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/12/pfizeranac-1.png https://qfrsolutions.com/mayne-vaults-ahead-in-u-s-with-652m-deal-for-teva-allergan-meds/ 2016-06-28T20:46:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/06/maynepharma-1.jpg https://qfrsolutions.com/leo-buys-rights-to-astrazeneca-s-skin-drug/ 2016-07-05T20:26:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/07/leopharma-1.jpg https://qfrsolutions.com/galderma-announces-fda-approval-of-full-prescription-strength-differin-gel-for-over-the-counter-acne-use/ 2016-07-08T22:06:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/07/Differin-1.jpg https://qfrsolutions.com/valeant-s-ex-ceo-michael-pearson-sells-nearly-100-million-in-company-stock/ 2016-07-13T23:38:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/07/MPearson-1.png https://qfrsolutions.com/journey-medical-corporation-launches-luxamend-wound-cream-and-ceracade-skin-barrier-emulsion/ 2016-07-25T17:40:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/10/JourneyLogo-1.gif https://qfrsolutions.com/nightmare-scenario-could-cramp-valeant-s-ability-to-cut-prices/ 2016-08-01T20:12:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/12/Val-1.png https://qfrsolutions.com/valeant-under-criminal-investigation-over-philidor-ties-wsj/ 2016-08-11T20:00:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/08/VALVAL-1.jpg https://qfrsolutions.com/allergan-s-newest-kybella-targets-bra-line-ankle-fat/ 2016-08-15T16:56:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/06/Allerganlogo-1.png https://qfrsolutions.com/dermatology-biotech-novan-goes-for-60m-ipo/ 2016-08-25T17:46:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/03/Novan-1.png https://qfrsolutions.com/celgene-off-label-marketing-lawsuit-documents-unsealed/ 2016-08-25T21:50:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/01/CelegeneLogo-1.png https://qfrsolutions.com/horizon-pharma-to-buy-raptor-pharma-for-800-mln/ 2016-09-12T18:29:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/09/HorizonRaptor-1.png https://qfrsolutions.com/allergan-to-buy-vitae-pharmaceuticals-for-639-million/ 2016-09-16T21:53:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/09/Vitae-1.png https://qfrsolutions.com/ipo-pop-durham-pharmaceutical-firm-novan-stock-skyrockets-70/ 2016-09-21T21:36:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/03/Novan-1.png https://qfrsolutions.com/samsung-biologics-korean-ipo-to-raise-as-much-as-2-billion/ 2016-10-04T17:51:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/10/SamsungBio-1.png https://qfrsolutions.com/eli-lilly-s-new-psoriasis-treatment-taltz-launches-first-ads-chasing-novartis-cosentyx-lead/ 2016-10-12T18:14:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/10/Lilly-1.jpg https://qfrsolutions.com/journey-medical-corporation-launches-targadox-oral-immediate-release-tablet-for-treatment-of-severe-acne/ 2016-10-17T15:51:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/10/JourneyLogo-1.gif https://qfrsolutions.com/encore-dermatology-inc-announces-launch-of-hylatopicplus-lotion/ 2016-10-17T16:05:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/05/EncoreDerm_d63fabbaa579a4a6f917709931cedf32-1.jpg https://qfrsolutions.com/allergan-recalls-some-tazorac-acne-gel/ 2016-10-20T22:09:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/06/Allerganlogo-1.png https://qfrsolutions.com/myovant-bumps-ipo-to-218m-with-pfizer-bb-biotech-aid/ 2016-10-27T18:41:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/10/Myovant-1.jpg https://qfrsolutions.com/qfr-solutions-earns-linkedin-s-top-specialist-firm/ 2016-11-01T20:58:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/02/QFR_Top25-1.png https://qfrsolutions.com/valeant-shares-plunge-as-it-slashes-guidance-again/ 2016-11-08T16:54:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/12/Val-1.png https://qfrsolutions.com/novartis-celgene-and-pfizer-trot-out-positive-data-in-red-hot-psoriatic-arthritis-race/ 2016-11-16T21:43:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/11/NCP-1.jpg https://qfrsolutions.com/novan-announces-statistically-significant-phase-2-clinical-trial-results-for-sb206/ 2016-12-01T22:26:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/03/Novan-1.png https://qfrsolutions.com/aclaris-starts-phase-1-trial-for-ati-50001-to-treat-alopecia-totalis-and-alopecia-universalis/ 2016-12-09T14:49:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/12/Aclaris-1.jpg https://qfrsolutions.com/valeant-appoints-william-d-humphries-as-evp-dermatology/ 2016-12-13T16:09:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/12/Val-1.png https://qfrsolutions.com/fda-approves-pfizer-ointment-for-itchy-skin-condition/ 2016-12-14T22:28:00+00:00 https://qfrsolutions.com/wp-content/uploads/2016/12/pfizeranac-1.png https://qfrsolutions.com/sun-pharma-announces-positive-topline-results-of-confirmatory-phase-3-clinical-trial-for-seciera-for-treatment-of-dry-eye/ 2017-01-04T21:58:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/03/SunPharmaLogo-1.jpg https://qfrsolutions.com/novan-licenses-sb204-to-sato-for-acne-in-japan/ 2017-01-18T23:03:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/03/Novan-1.png https://qfrsolutions.com/http-www-reuters-com-article-us-actelion-johnson-johnson-iduskbn15a0km/ 2017-01-26T18:37:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/01/johnson-1.jpg https://qfrsolutions.com/encore-dermatology-inc-announces-launch-of-tridesilontm-desonide-cream-0-05/ 2017-01-27T17:39:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/05/EncoreDerm_d63fabbaa579a4a6f917709931cedf32-1.jpg https://qfrsolutions.com/allergan-continues-m-a-spree-with-2-5b-deal-to-beef-up-aesthetics-unit/ 2017-02-13T18:33:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/02/allerganzeltiq-1.jpg https://qfrsolutions.com/novan-provides-update-on-sb204-development-program/ 2017-03-06T18:06:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/03/Novan-1.png https://qfrsolutions.com/sun-pharma-s-indirect-arm-taro-to-acquire-thallion-pharmaceuticals/ 2017-03-17T18:32:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/03/Taro-1.png https://qfrsolutions.com/cipher-pharmaceuticals-appoints-robert-d-tessarolo-as-ceo/ 2017-03-21T19:09:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/03/cipher-1.jpg https://qfrsolutions.com/allergan-paratek-hit-late-stage-acne-goals-prep-for-sarecycline-nda/ 2017-03-27T18:46:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/03/paratek-1.jpg https://qfrsolutions.com/9-signs-that-you-re-an-ambivert/ 2017-04-12T20:43:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/04/ambivert-1.jpg https://qfrsolutions.com/cardinal-health-to-fork-over-6-1b-for-three-medtronic-units/ 2017-04-19T17:23:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/04/CardinalHealth-1.jpg https://qfrsolutions.com/ex-kythera-team-raises-40m-for-dermatology-clinical-trials/ 2017-04-25T16:38:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/04/Sienna-1.jpg https://qfrsolutions.com/alphaeon-submits-biologics-license-application-for-dwp-450-neuromodulator/ 2017-05-17T23:06:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/05/alphaeon-1.jpg https://qfrsolutions.com/stuart-raetzman-appointed-ceo-of-nestle-skin-health/ 2017-05-22T19:26:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/05/NestleStuart-1.jpg https://qfrsolutions.com/allergan-to-acquire-keller-medical-inc-adding-keller-funnel-to-company-s-leading-plastic-surgery-portfolio/ 2017-06-08T21:21:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/06/Allerganlogo-1.png https://qfrsolutions.com/fortress-biotech-announces-filing-of-provisional-patent-application-for-caelum-biosciences-cael-101/ 2017-07-17T20:36:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/07/Fortress-1.jpg https://qfrsolutions.com/has-the-brent-saunders-price-hike-limit-become-a-de-facto-pharma-rule/ 2017-08-14T19:22:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/08/PillsMoney-1.jpg https://qfrsolutions.com/prollenium-medical-technologies-inc-announces-u-s-fda-approval-for-its-cross-linked-hyaluronic-acid-dermal-filler/ 2017-08-17T23:36:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/08/Prollenium-1.jpg https://qfrsolutions.com/encore-makes-pipeline-play-licensing-psoriasis-drug-from-dr-reddy-s/ 2017-08-22T16:06:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/05/EncoreDerm_d63fabbaa579a4a6f917709931cedf32-1.jpg https://qfrsolutions.com/dermavant-sciences-appoints-vince-ippolito-as-president-and-chief-operating-officer/ 2017-10-01T19:54:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/10/Dermavant-1.jpg https://qfrsolutions.com/abbvie-s-risankizumab-blows-away-aging-rivals-in-phase-3/ 2017-11-03T15:33:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/11/Abbvie1-1.jpg https://qfrsolutions.com/dr-reddy-s-announces-approval-of-impoyz-clobetasol-propionate-cream-0-025-first-cycle-nda-approval/ 2017-12-05T17:52:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/05/EncoreDerm_d63fabbaa579a4a6f917709931cedf32-1.jpg https://qfrsolutions.com/aclaris-therapeutics-receives-fda-approval-for-eskata-hydrogen-peroxide-topical-solution-40-w-w-for-the-treatment-of-raised-seborrheic-keratoses-sks/ 2017-12-18T20:38:00+00:00 https://qfrsolutions.com/wp-content/uploads/2017/12/Aclaris-1.jpg https://qfrsolutions.com/celgene-s-7-billion-purchase-is-great-for-drug-inventors-is-it-great-for-celgene/ 2018-01-08T18:52:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/01/CelegeneLogo-1.png https://qfrsolutions.com/qfr-solutions-earns-another-top-spot/ 2018-02-01T18:51:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/02/LinkedIn-Engaged-1.jpg https://qfrsolutions.com/sienna-biopharmaceuticals-announces-first-patient-dosed-in-first-in-human-trial-of-topical-sna-126/ 2018-02-14T15:58:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/02/Sienna-1.jpg https://qfrsolutions.com/cigna-to-acquire-express-scripts-for-67-billion/ 2018-03-08T20:11:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/03/Cigna-1.jpg https://qfrsolutions.com/sun-pharma-announces-u-s-fda-approval-of-ilumya-tildrakizumab-asmn-for-the-treatment-of-moderate-to-severe-plaque-psoriasis/ 2018-03-22T16:04:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/03/SunPharmaLogo-1.jpg https://qfrsolutions.com/datavant-acquires-universal-patient-key-and-closes-40m-financing-round/ 2018-04-30T16:11:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/04/Datavant-1.jpg https://qfrsolutions.com/encore-dermatology-inc-announces-the-launch-of-impoyztm-clobetasol-propionate-cream-0-025-a-newly-formulated-high-potency-topical-corticosteroid/ 2018-05-01T15:41:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/05/EncoreDerm_d63fabbaa579a4a6f917709931cedf32-1.jpg https://qfrsolutions.com/takeda-finally-inks-a-deal-to-buy-shire-in-one-of-the-biggest-pharma-takeovers-ever/ 2018-06-04T15:56:16+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/TakedaShire-1.jpg https://qfrsolutions.com/verrica-seeks-86m-ipo-to-take-on-compounded-dermatology-drug/ 2018-06-04T15:58:33+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Verrica-1.jpeg https://qfrsolutions.com/specialty-pharmaceutical-sales-representative/ 2018-06-08T11:49:11+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Checkmark-Box-1-1.jpg https://qfrsolutions.com/specialty-sales-representative/ 2018-06-19T18:48:34+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/quotation-1.jpg https://qfrsolutions.com/specialty-sales-representative-2/ 2018-06-19T20:12:18+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Thumbs-Up2-1.jpg https://qfrsolutions.com/director-of-sales/ 2018-06-19T20:44:54+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/quotation-1.jpg https://qfrsolutions.com/regional-sales-manager-medical-devices/ 2018-06-19T20:56:42+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Checkmark-Box-1-1.jpg https://qfrsolutions.com/former-dermatopatholoby-lab-administrator/ 2018-06-19T21:01:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Thumbs-Up2-1.jpg https://qfrsolutions.com/president-aesthetics/ 2018-06-19T21:02:57+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Checkmark-Box-1-1.jpg https://qfrsolutions.com/ceo-clinical-program-director/ 2018-06-19T21:04:14+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/quotation-1.jpg https://qfrsolutions.com/dermatology-specialty-representative/ 2018-06-19T21:05:11+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Thumbs-Up2-1.jpg https://qfrsolutions.com/2445-2/ 2018-06-19T21:08:03+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Checkmark-Box-1-1.jpg https://qfrsolutions.com/2446-2/ 2018-06-19T21:10:19+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/quotation-1.jpg https://qfrsolutions.com/2447-2/ 2018-06-19T21:11:03+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Thumbs-Up2-1.jpg https://qfrsolutions.com/2448-2/ 2018-06-19T21:11:39+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Checkmark-Box-1-1.jpg https://qfrsolutions.com/2449-2/ 2018-06-19T21:12:27+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/quotation-1.jpg https://qfrsolutions.com/2450-2/ 2018-06-19T21:13:42+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Thumbs-Up2-1.jpg https://qfrsolutions.com/2451-2/ 2018-06-19T21:14:40+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Checkmark-Box-1-1.jpg https://qfrsolutions.com/amazon-to-buy-pillpack-in-potentially-disruptive-drug-retail-push/ 2018-06-28T21:54:25+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Amazon-PillPack-1.jpg https://qfrsolutions.com/cassiopea-announces-very-positive-top-line-phase-3-results-for-winlevi-clascoterone-cream-in-treating-acne/ 2018-07-10T19:02:09+00:00 https://qfrsolutions.com/wp-content/uploads/2018/07/Cassiopea-1.jpg https://qfrsolutions.com/dermavant-inks-330m-deal-for-gsks-phase-3-ready-psoriasis-drug/ 2018-07-12T18:03:36+00:00 https://qfrsolutions.com/wp-content/uploads/2017/10/Dermavant-1.jpg https://qfrsolutions.com/sienna-biopharmaceuticals-successfully-completes-maximal-use-safety-study-of-sna-120-in-patients-with-itch-associated-with-psoriasis/ 2018-07-24T16:33:31+00:00 https://qfrsolutions.com/wp-content/uploads/2017/04/Sienna-1.jpg https://qfrsolutions.com/bayer-sells-prescription-dermatology-brands-to-denmarks-leo-pharma/ 2018-07-31T18:01:26+00:00 https://qfrsolutions.com/wp-content/uploads/2018/07/BaylerLeo-1.jpg https://qfrsolutions.com/allergan-preludes-major-selloffs-with-650m-almirall-dermatology-sale/ 2018-08-03T19:48:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/08/Allergan-Almirall-1.jpg https://qfrsolutions.com/2713-2/ 2018-08-13T20:42:34+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/quotation-1.jpg https://qfrsolutions.com/cigna-express-scripts-shareholders-approve-67b-deal/ 2018-08-24T19:08:28+00:00 https://qfrsolutions.com/wp-content/uploads/2018/03/Cigna-1.jpg https://qfrsolutions.com/allergan-to-acquire-bonti-adding-new-neurotoxin-programs-to-medical-aesthetics-pipeline/ 2018-09-14T20:52:19+00:00 https://qfrsolutions.com/wp-content/uploads/2017/06/Allerganlogo-1.png https://qfrsolutions.com/doj-clears-cignas-planned-acquisition-of-express-scripts/ 2018-09-17T20:39:59+00:00 https://qfrsolutions.com/wp-content/uploads/2018/03/Cigna-1.jpg https://qfrsolutions.com/alexion-snaps-up-another-biotech-paying-1-2b-for-syntimmune/ 2018-09-26T16:54:20+00:00 https://qfrsolutions.com/wp-content/uploads/2018/09/alexion-logo-big-1.jpg https://qfrsolutions.com/unitedhealth-buys-genoa-healthcare-adding-more-than-400-pharmacies-to-its-pbm/ 2018-10-02T18:14:00+00:00 https://qfrsolutions.com/wp-content/uploads/2018/10/Genoa-1.jpg https://qfrsolutions.com/pharma-sanofi-regeneron-score-positive-dupixent-data-in-sinusitis-as-they-await-key-fda-asthma-verdict/ 2018-10-16T20:52:18+00:00 https://qfrsolutions.com/wp-content/uploads/2018/10/SANOFI-REGENERON-1.jpg https://qfrsolutions.com/telehealth-firm-98point6-nets-50m-in-round-led-by-goldman-sachs/ 2018-10-31T17:09:02+00:00 https://qfrsolutions.com/wp-content/uploads/2018/10/98point6-1.jpg https://qfrsolutions.com/sienna-biopharmaceuticals-announces-its-topical-non-steroidal-trka-inhibitor-sna-120-0-05-demonstrated-significant-impact-on-psoriasis-in-phase-2b-study-and-plans-to-initiate-phase-3-psoriasis-tria/ 2018-12-03T16:10:02+00:00 https://qfrsolutions.com/wp-content/uploads/2018/02/Sienna-1.jpg https://qfrsolutions.com/bristol-myers-squibb-to-acquire-celgene-to-create-a-premier-innovative-biopharma-company/ 2019-01-03T17:30:37+00:00 https://qfrsolutions.com/wp-content/uploads/2019/01/BMSC-1.jpg https://qfrsolutions.com/anthem-moves-up-launch-of-its-pbm-to-second-quarter-of-2019/ 2019-01-30T17:01:58+00:00 https://qfrsolutions.com/wp-content/uploads/2019/01/Anthem3-1.jpg https://qfrsolutions.com/fda-approves-medtronic-device-for-sealing-off-deeper-smaller-brain-aneurysms/ 2019-02-08T20:46:07+00:00 https://qfrsolutions.com/wp-content/uploads/2019/02/Recall-for-Medtronic-Deep-Brain-Stimulation-Lead-Kit-and-Activa-Dystonia-HDE-Kit-300x225-1.jpg https://qfrsolutions.com/sun-pharmaceutical-industries-inc-announces-plans-to-present-19-data-abstracts-on-ilumya-for-moderate-to-severe-plaque-psoriasis-at-american-academy-of-dermatology-2019-annual-meeting/ 2019-02-28T15:57:32+00:00 https://qfrsolutions.com/wp-content/uploads/2018/03/SunPharmaLogo-1.jpg https://qfrsolutions.com/stryker-acquires-orthospace-and-its-rotator-cuff-implant-in-220m-deal/ 2019-03-15T17:48:24+00:00 https://qfrsolutions.com/wp-content/uploads/2019/03/stryk-1.jpg https://qfrsolutions.com/biofrontera-inc-usa-acquires-cutanea-life-sciences-inc-usa/ 2019-03-25T16:25:44+00:00 https://qfrsolutions.com/wp-content/uploads/2019/03/BIOFRONTERA-1.png https://qfrsolutions.com/allergan-acquires-envy-medical-inc-adding-skin-resurfacing-dermalinfusion-system-to-best-in-class-medical-aesthetics-portfolio/ 2019-03-26T15:48:14+00:00 https://qfrsolutions.com/wp-content/uploads/2017/06/Allerganlogo-1.png https://qfrsolutions.com/encore-dermatology-inc-acquires-sernivo-trianex-and-promiseb/ 2019-04-02T15:59:43+00:00 https://qfrsolutions.com/wp-content/uploads/2018/05/EncoreDerm_d63fabbaa579a4a6f917709931cedf32-1.jpg https://qfrsolutions.com/bellus-medical-the-aesthetics-division-of-crown-laboratories-announces-acquisition-of-healeon-medicals-hd-prp-system-for-aesthetic-marketplace/ 2019-05-28T17:01:47+00:00 https://qfrsolutions.com/wp-content/uploads/2019/05/bellusmedical-logo-v3-1.jpg https://qfrsolutions.com/pharma-celgene-say-goodbye-to-otezla-bms-agrees-to-sell-psoriasis-drug-to-clear-74b-merger/ 2019-06-24T17:53:25+00:00 https://qfrsolutions.com/wp-content/uploads/2018/01/CelegeneLogo-1.png https://qfrsolutions.com/abbvie-looks-beyond-humira-with-63-billion-deal-for-botox-maker-allergan/ 2019-06-25T17:16:06+00:00 https://qfrsolutions.com/wp-content/uploads/2019/06/abbvieallergan-1.jpg https://qfrsolutions.com/cassiopea-anounces-fda-submission-of-new-drug-application-for-clascoterone-cream-1-the-first-new-mechanism-of-action-for-acne-in-nearly-40-years/ 2019-08-20T16:00:53+00:00 https://qfrsolutions.com/wp-content/uploads/2018/07/Cassiopea-1.jpg https://qfrsolutions.com/ucb-strikes-2-5b-deal-to-buy-ra-for-rival-to-alexions-soliris/ 2019-10-10T18:59:56+00:00 https://qfrsolutions.com/wp-content/uploads/2019/10/ucb2-1.png https://qfrsolutions.com/stryker-to-buy-orthopedic-device-maker-wright-medical-for-4b/ 2019-11-05T16:06:59+00:00 https://qfrsolutions.com/wp-content/uploads/2019/03/stryk-1.jpg https://qfrsolutions.com/39121-2/ 2019-11-05T17:54:13+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Thumbs-Up2-1.jpg https://qfrsolutions.com/fortress-biotech-ranked-in-top-10-of-deloittes-2019-technology-fast-500/ 2019-11-25T19:15:15+00:00 https://qfrsolutions.com/wp-content/uploads/2017/07/Fortress-1.jpg https://qfrsolutions.com/arcutis-eyes-100m-ipo-to-bankroll-dermatology-programs/ 2020-01-07T18:25:38+00:00 https://qfrsolutions.com/wp-content/uploads/2020/01/Arcutis-BioTherapeutics-1.jpg https://qfrsolutions.com/pwc-report-sees-pharma-biotech-deals-to-be-extremely-active-in-2020/ 2020-01-27T20:26:09+00:00 https://qfrsolutions.com/wp-content/uploads/2020/01/PWC-logo-1.jpg https://qfrsolutions.com/neauvia-north-america-launches-the-first-and-only-fda-class-ii-cleared-plasma-device-in-the-u-s-market/ 2020-03-13T21:31:35+00:00 https://qfrsolutions.com/wp-content/uploads/2020/03/NVA-1-1.png https://qfrsolutions.com/jj-tracks-the-path-to-a-covid-19-vaccine-in-new-online-news-series/ 2020-04-15T20:47:47+00:00 https://qfrsolutions.com/wp-content/uploads/2020/04/JJ2-1.png https://qfrsolutions.com/medtech-fda-authorizes-nasa-designed-ventilator-for-covid-19/ 2020-05-04T17:30:17+00:00 https://qfrsolutions.com/wp-content/uploads/2020/05/nasa3-1.jpg https://qfrsolutions.com/medtech-breakthrough-honors-standout-digital-health-and-medical-technology-innovation-in-2020-medtech-breakthrough-awards-program/ 2020-05-19T18:41:31+00:00 https://qfrsolutions.com/wp-content/uploads/2020/05/gI_126775_NewsImage_vcsPRAsset_3525833_126775_711c0a6d-51c6-4a63-b7ed-d941f2fe6940_0-1.png https://qfrsolutions.com/40872-2/ 2020-06-05T21:49:14+00:00 https://qfrsolutions.com/wp-content/uploads/2018/06/Checkmark-Box-1-1.jpg https://qfrsolutions.com/nestle-plunks-down-2-1b-to-acquire-aimmune-and-blockbuster-hopeful-peanut-allergy-med/ 2020-08-31T18:30:26+00:00 https://qfrsolutions.com/wp-content/uploads/2020/08/nestle_logo2-1.gif https://qfrsolutions.com/journey-medical-corp-kicks-off-journey-with-the-experts-educational-initiative-with-rania-agha-md/ 2020-10-06T18:29:58+00:00 https://qfrsolutions.com/wp-content/uploads/2016/10/JourneyLogo-1.gif https://qfrsolutions.com/journey-medical-corp-announces-new-journey-with-the-experts-video-featuring-marc-darst-md/ 2020-11-16T15:32:12+00:00 https://qfrsolutions.com/wp-content/uploads/2016/10/JourneyLogo-1.gif https://qfrsolutions.com/salesforce-signs-definitive-agreement-to-acquire-slack/ 2020-12-02T15:23:01+00:00 https://qfrsolutions.com/wp-content/uploads/2020/12/salesforce-slack-logos-3-1.jpg https://qfrsolutions.com/back-to-beauty-former-allergan-chief-saunders-scoops-up-aesthetics-company-in-1-1b-deal/ 2020-12-11T18:48:27+00:00 https://qfrsolutions.com/wp-content/uploads/2020/12/vesper-hydrafacial-1-1.png https://qfrsolutions.com/unitedhealth-groups-optum-to-buy-change-healthcare-for-13b/ 2021-01-06T19:43:32+00:00 https://qfrsolutions.com/wp-content/uploads/2021/01/UHC-Change-1.jpg https://qfrsolutions.com/medtech-fda-clears-novel-neck-collar-to-help-protect-student-athletes-brains-from-sports-related-injuries/ 2021-03-01T18:13:34+00:00 https://qfrsolutions.com/wp-content/uploads/2021/03/Q30-1.jpg https://qfrsolutions.com/fortress-biotechs-partner-company-journey-medical-corporation-in-licenses-and-launches-accutane-for-the-treatment-of-severe-recalcitrant-nodular-acne/ 2021-03-22T14:59:42+00:00 https://qfrsolutions.com/wp-content/uploads/2021/03/jmc-1.jpg https://qfrsolutions.com/journey-medical-corporation-enters-into-a-definitive-agreement-with-dermira-inc-a-wholly-owned-subsidiary-of-eli-lilly-and-company-to-acquire-qbrexza/ 2021-04-01T15:54:28+00:00 https://qfrsolutions.com/wp-content/uploads/2021/03/jmc-1.jpg https://qfrsolutions.com/biogens-aducanumab-crosses-fda-finish-line-just-in-time-to-save-its-business/ 2021-06-08T16:02:34+00:00 https://qfrsolutions.com/wp-content/uploads/2021/06/Biogen-1.jpg https://qfrsolutions.com/journey-medical-corporation-enters-into-a-definitive-agreement-with-dr-reddys-laboratories-ltd-to-develop-and-commercialize-dfd-29-for-the-treatment-of-rosacea/ 2021-06-30T15:11:49+00:00 https://qfrsolutions.com/wp-content/uploads/2021/03/jmc-1.jpg https://qfrsolutions.com/cassiopea-spa-and-sun-pharma-announce-signing-of-license-and-supply-agreements-for-winlevi-clascoterone-cream-1-in-us-and-canada/ 2021-07-26T14:54:28+00:00 https://qfrsolutions.com/wp-content/uploads/2018/07/Cassiopea-1.jpg https://qfrsolutions.com/crown-laboratories-to-acquire-strivectin-the-1-independent-prestige-skincare-company-in-the-u-s/ 2021-09-07T23:26:03+00:00 https://qfrsolutions.com/wp-content/uploads/2021/09/Crown-Lab-1.jpg https://qfrsolutions.com/amgen-reveals-midphase-eczema-data-behind-its-400m-bet/ 2021-10-04T16:47:58+00:00 https://qfrsolutions.com/wp-content/uploads/2021/10/AMGEN-1.jpg https://qfrsolutions.com/journey-medical-corporation-announces-launch-of-its-initial-public-offering/ 2021-11-08T17:14:15+00:00 https://qfrsolutions.com/wp-content/uploads/2016/10/JourneyLogo-1.gif https://qfrsolutions.com/journey-medical-corporation-acquires-two-fda-approved-topical-minocycline-products-and-molecule-stabilizing-technology-mst-franchise-from-vyne-therapeutics-inc/ 2022-01-13T17:38:53+00:00 https://qfrsolutions.com/wp-content/uploads/2021/03/jmc-1.jpg https://qfrsolutions.com/epi-health-announces-acquisition-by-novan-inc-to-create-fully-integrated-specialty-dermatology-company/ 2022-03-14T20:00:32+00:00 https://qfrsolutions.com/wp-content/uploads/2022/03/EPI-Health-Novan-1.jpg https://qfrsolutions.com/loreal-to-acquire-skinbetter-science/ 2022-09-23T23:02:23+00:00 https://qfrsolutions.com/wp-content/uploads/2022/09/SB-1.png https://qfrsolutions.com/rick-beck-founding-recruiter-on-forbes-jobs/ 2023-05-11T20:09:03+00:00 https://qfrsolutions.com/wp-content/uploads/2023/05/FJ-Recruiter-1.jpg https://qfrsolutions.com/wp-content/uploads/2023/05/Rick-Forbes.jobs_-1.jpg https://qfrsolutions.com/leo-pharma-to-acquire-timber-pharmaceuticals/ 2023-08-23T22:01:30+00:00 https://qfrsolutions.com/wp-content/uploads/2014/07/LeoPharmaceuticals-1.jpg https://qfrsolutions.com/incyte-fresh-off-gaining-morphosys-drug-buys-escient-for-750m/ 2024-04-23T20:43:05+00:00 https://qfrsolutions.com/wp-content/uploads/2024/04/Incyte-1.jpg https://qfrsolutions.com/42381-2/ 2024-09-18T20:44:06+00:00 https://qfrsolutions.com/wp-content/uploads/2024/09/Dermavant-1.jpg https://qfrsolutions.com/fda-blesses-atopic-dermatitis-label-expansions-for-organons-vtama-galdermas-nemluvio/ 2024-12-16T18:29:44+00:00 https://qfrsolutions.com/wp-content/uploads/2024/12/Organon-Galderma-1.jpg https://qfrsolutions.com/jazz-hands-over-935m-to-buy-chimerix-for-near-approval-cancer-drug/ 2025-03-05T19:06:02+00:00 https://qfrsolutions.com/wp-content/uploads/2025/03/Jazz-Pharmaceuticals-1.jpg